Oncolytics Biotech Inc. (ONCY) - Prakiraan wutah bathi kanggo taun ngarep

The forward-looking earnings per share growth forecast demonstrates the potential of Pelareorep, which activates immunity against tumors for Oncolytics Biotech Inc. (ONCY). The 21.80 level captures fresh values, reflecting synergy with pharma behemoths in the development of combination therapies. The brand's high authority within the scientific community is confirmed by the safety of viral platforms, making the trend of analyst expectations a key indicator for assessing the asset's value.

ONCY - Proyeksi tambahing bathi saben saham ing taun ngarep Oncolytics Biotech, Inc. ing rentang 04.07.2022 - 14.11.2026

Rincian metrik lan analitis perusahaan Oncolytics (ONCY)

- rega lan prakiraan konsensus rega:

Bagan rega Oncolytics Biotech Inc.|ONCY - Bagan rega target

- indikator kapitalisasi pasar:

Kapitalisasi pasar Oncolytics Biotech Inc.|ONCY - Nilai Perusahaan

- indikator kapitalisasi buku:

Nilai Akuntansi saben Saham Oncolytics Biotech|ONCY - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku oncolyticsbiotech.com|ONCY - Nilai Total Aset Perusahaan

- rincian utang lan likuiditas:

Utang marang Ekuitas Oncolytics Biotech Inc.|ONCY - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas oncolyticsbiotech.com|ONCY - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Oncolytics|ONCY - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Oncolytics Biotech|Likuiditas cepet oncolyticsbiotech.com

- statistik bathi lan rasio pasar:

ONCY - Penghasilan resik perusahaan|Bathi sing dikarepake Oncolytics Biotech Inc.|ONCY - Pangali rega marang bathi|Pangali Forward P/E oncolyticsbiotech.com|ONCY - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Oncolytics Biotech|ONCY - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Oncolytics Biotech|ONCY - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan oncolyticsbiotech.com|ONCY - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Oncolytics Biotech Inc.

- informasi babagan volume dodolan lan pendapatan:

ONCY - Total dodolan perusahaan|Prakiraan volume dodolan Oncolytics Biotech|ONCY - Koefisien rega marang pendapatan|Multiplikator Forward P/S Oncolytics

Pambiji fundamental perusahaan:ONCY, Oncolytics Biotech, Inc.

This indicator measures the expected growth rate of earnings per share, reflecting the analysts' consensus forecast for future profitability. Assessing the EPS dynamics for the coming year determines whether the market is pricing in an increase in business efficiency. The metric is calculated as the percentage deviation of projected earnings from current values. For Oncolytics Biotech Inc. (ONCY), which depends on R&D funding and Phase II clinical trials, this trend signals the level of expert confidence in the commercialization of its drugs.

Analisis perusahaan pesaing

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Geron Corporation|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NBTX|Prakiraan wutah bathi kanggo taun ngarep BCYC|Prakiraan wutah bathi kanggo taun ngarep CytomX Therapeutics Inc (CTMX)|Perspective Therapeutics, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep GNLX (Genelux Corp)|Molecular Partners AG - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep LSTA|moleculin.com (MBRX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Galera (GRTX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Molecular Templates Corp